Programme
Target class
Status
Stage
Discovery
Lead ID
pRECLINICAL
IND-E
Oncology
CPI Agonist
GlobalBio
Oncology
CPI Agonist
GlobalBio
Oncology
GlobalBio
CPI Agonist
Discovery
Lead ID
pRECLINICAL
IND-E
Cardiovascular
Thrombosis
GPCR Antagonist
Wholly-owned
Cardiovascular
Thrombosis
GPCR Antagonist
Wholly-owned
Cardiovascular
Wholly-owned
GPCR Antagonist
Discovery
Lead ID
pRECLINICAL
IND-E
Oncology
TMP ANTAGONIST
Top 20 Pharma
Oncology
TMP ANTAGONIST
Top 20 Pharma
Oncology
Top 20 Pharma
TMP ANTAGONIST
Discovery
Lead ID
pRECLINICAL
IND-E
CNS
GPCR Antagonist
Top 20 Pharma
CNS
GPCR Antagonist
Top 20 Pharma
CNS
Top 20 Pharma
GPCR Antagonist
Discovery
Lead ID
pRECLINICAL
IND-E
Undisclosed
GPCR Agonist
Nxera
Undisclosed
GPCR Agonist
Nxera
Undisclosed
Nxera
GPCR Agonist
Discovery
Lead ID
pRECLINICAL
IND-E
Fibrosis
IPF
GPCR Antagonist
Wholly-owned
Fibrosis
IPF
GPCR Antagonist
Wholly-owned
Fibrosis
Wholly-owned
GPCR Antagonist
Discovery
Lead ID
pRECLINICAL
IND-E
Cardiometabolic
Mash
TMR Agonist
Wholly-owned
Cardiometabolic
Mash
TMR Agonist
Wholly-owned
Cardiometabolic
Wholly-owned
TMR Agonist
Discovery
Lead ID
pRECLINICAL
IND-E
©2026 Antiverse. All rights reserved.
©2026 Antiverse. All rights reserved.